secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001588978-23-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PROCEPT BioRobotics Q1 revenue up 72% to $24.4M; raises FY2023 revenue guidance to $128M
--------------------------------------------------------------------------------

- Total revenue $24.4M (+72% YoY); U.S. handpiece/consumables $11.8M (+165% YoY).
- Net loss $28.5M vs $17.2M; Adjusted EBITDA loss $23.9M vs $13.5M.
- FY2023 revenue guidance raised to $128M (from $125M); gross margin guidance ~54% (from ~53%).
- United Healthcare positive coverage policy effective June 1, 2023; national sales contract with largest U.S. IDN signed April 1.
- U.S. install base 192 AquaBeam systems; monthly utilization per account 6.3, up 14% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000158897823000012/0001588978-23-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000158897823000012/prct-20230427.htm
  HTML page:      https://secwatch.observer/filing/0001588978-23-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer